APO Research
Talk to an analyst

APO RESEARCH · REPORT

ELISpot and FluoroSpot Assay

The enzyme-linked immune absorbent spot (ELISpot) is a type of assay that focuses on quantitatively measuring the frequency of cytokine secretion for a single cell. The ELISpot Assay is also a form of immunostaining since it is classified as a technique that uses antibodies to detect a protein analyte, with the word analyte referring to any biological or chemical substance being identified or measured.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The enzyme-linked immune absorbent spot (ELISpot) is a type of assay that focuses on quantitatively measuring the frequency of cytokine secretion for a single cell. The ELISpot Assay is also a form of immunostaining since it is classified as a technique that uses antibodies to detect a protein analyte, with the word analyte referring to any biological or chemical substance being identified or measured.

Selected research

Market Analysis & Forecast

Global ELISpot and FluoroSpot Assay Market Analysis and Forecast 2026-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchELISpot and FluoroSpot Assay Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal ELISpot and FluoroSpot Assay Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal ELISpot and FluoroSpot Assay Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal ELISpot and FluoroSpot Assay Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal ELISpot and FluoroSpot Assay Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The enzyme-linked immune absorbent spot (ELISpot) is a type of assay that focuses on quantitatively measuring the frequency of cytokine secretion for a single cell. The ELISpot Assay is also a form of immunostaining since it is classified as a technique that uses antibodies to detect a protein analyte, with the word analyte referring to any biological or chemical substance being identified or measured.

Global eLISpot and fluoroSpot assay main players include CP Kelco, DowDuPont (Danisco), Cargill, Herbstreith & Fox, Andre Group, Silvateam, Naturex, Ceamsa, Anhui Jinfeng Pectin, Pomona’s Universal Pectin, Anhui Yuning, Bio-Technology, etc., totally accounting for about 80%. North America is the largest market, with s share over 45%. As for the types of products, it can be divided into assay kit and analyzer. The most common product is assay kit, holding a share over 62%. In terms of applications, it is widely used in diagnostic and research. The most application is research, with a share over 64%.

Report Includes

Read the full market overview

This report presents an overview of global market for ELISpot and FluoroSpot Assay, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of ELISpot and FluoroSpot Assay, also provides the revenue of main regions and countries. Of the upcoming market potential for ELISpot and FluoroSpot Assay, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the ELISpot and FluoroSpot Assay revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global ELISpot and FluoroSpot Assay market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for ELISpot and FluoroSpot Assay revenue, projected growth trends, production technology, application and end-user industry.

ELISpot and FluoroSpot Assay Segment by Company

Oxford Immunotec

Cellular Technology Limited

BD

AID GmbH

Mabtech

Bio-Techne

Lophius Biosciences

Abcam

Biotech Investissement Group

U-CyTech biosciences.

ELISpot and FluoroSpot Assay Segment by Type

Assay Kit

Analyzer

Others

ELISpot and FluoroSpot Assay Segment by Application

Diagnostic

Research

ELISpot and FluoroSpot Assay Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ELISpot and FluoroSpot Assay market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of ELISpot and FluoroSpot Assay and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ELISpot and FluoroSpot Assay.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of ELISpot and FluoroSpot Assay in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of ELISpot and FluoroSpot Assay company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, ELISpot and FluoroSpot Assay revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global ELISpot and FluoroSpot Assay Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Assay Kit Major Player Table 3. Analyzer Major Player Table 4. Others Major Player Table 5. Global ELISpot and FluoroSpot Assay Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Diagnostic Major Player Table 7. Research Major Player Table 8. ELISpot and FluoroSpot Assay Industry Trends Table 9. ELISpot and FluoroSpot Assay Industry Drivers Table 10. ELISpot and FluoroSpot Assay Industry Opportunities and Challenges Table 11. ELISpot and FluoroSpot Assay Industry Restraints Table 12. Global ELISpot and FluoroSpot Assay Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global ELISpot and FluoroSpot Assay Market Size by Region (2021-2026) & (US$ Million) Table 14. Global ELISpot and FluoroSpot Assay Market Share by Region (2021-2026) Table 15. Global ELISpot and FluoroSpot Assay Market Size by Region (2027-2032) & (US$ Million) Table 16. Global ELISpot and FluoroSpot Assay Market Share by Region (2027-2032) Table 17. Global ELISpot and FluoroSpot Assay Revenue by Players (US$ Million) & (2021-2026) Table 18. Global ELISpot and FluoroSpot Assay Revenue Market Share by Players (2021-2026) Table 19. Global ELISpot and FluoroSpot Assay Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global ELISpot and FluoroSpot Assay Key Players Headquarters & Area Served Table 21. Global ELISpot and FluoroSpot Assay Players, Product Type & Application Table 22. Global ELISpot and FluoroSpot Assay Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global ELISpot and FluoroSpot Assay by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global ELISpot and FluoroSpot Assay Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global ELISpot and FluoroSpot Assay Revenue by Type (2021-2026) & (US$ Million) Table 27. Global ELISpot and FluoroSpot Assay Revenue by Type (2027-2032) & (US$ Million) Table 28. Global ELISpot and FluoroSpot Assay Revenue Market Share by Type (2021-2026) Table 29. Global ELISpot and FluoroSpot Assay Revenue Market Share by Type (2027-2032) Table 30. Global ELISpot and FluoroSpot Assay Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global ELISpot and FluoroSpot Assay Revenue by Application (2021-2026) & (US$ Million) Table 32. Global ELISpot and FluoroSpot Assay Revenue by Application (2027-2032) & (US$ Million) Table 33. Global ELISpot and FluoroSpot Assay Revenue Market Share by Application (2021-2026) Table 34. Global ELISpot and FluoroSpot Assay Revenue Market Share by Application (2027-2032) Table 35. Oxford Immunotec Company Information Table 36. Oxford Immunotec Business Overview Table 37. Oxford Immunotec ELISpot and FluoroSpot Assay Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Oxford Immunotec ELISpot and FluoroSpot Assay Product Portfolio Table 39. Oxford Immunotec Recent Development Table 40. Cellular Technology Limited Company Information Table 41. Cellular Technology Limited Business Overview Table 42. Cellular Technology Limited ELISpot and FluoroSpot Assay Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Cellular Technology Limited ELISpot and FluoroSpot Assay Product Portfolio Table 44. Cellular Technology Limited Recent Development Table 45. BD Company Information Table 46. BD Business Overview Table 47. BD ELISpot and FluoroSpot Assay Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. BD ELISpot and FluoroSpot Assay Product Portfolio Table 49. BD Recent Development Table 50. AID GmbH Company Information Table 51. AID GmbH Business Overview Table 52. AID GmbH ELISpot and FluoroSpot Assay Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. AID GmbH ELISpot and FluoroSpot Assay Product Portfolio Table 54. AID GmbH Recent Development Table 55. Mabtech Company Information Table 56. Mabtech Business Overview Table 57. Mabtech ELISpot and FluoroSpot Assay Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Mabtech ELISpot and FluoroSpot Assay Product Portfolio Table 59. Mabtech Recent Development Table 60. Bio-Techne Company Information Table 61. Bio-Techne Business Overview Table 62. Bio-Techne ELISpot and FluoroSpot Assay Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Bio-Techne ELISpot and FluoroSpot Assay Product Portfolio Table 64. Bio-Techne Recent Development Table 65. Lophius Biosciences Company Information Table 66. Lophius Biosciences Business Overview Table 67. Lophius Biosciences ELISpot and FluoroSpot Assay Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Lophius Biosciences ELISpot and FluoroSpot Assay Product Portfolio Table 69. Lophius Biosciences Recent Development Table 70. Abcam Company Information Table 71. Abcam Business Overview Table 72. Abcam ELISpot and FluoroSpot Assay Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Abcam ELISpot and FluoroSpot Assay Product Portfolio Table 74. Abcam Recent Development Table 75. Biotech Investissement Group Company Information Table 76. Biotech Investissement Group Business Overview Table 77. Biotech Investissement Group ELISpot and FluoroSpot Assay Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Biotech Investissement Group ELISpot and FluoroSpot Assay Product Portfolio Table 79. Biotech Investissement Group Recent Development Table 80. U-CyTech biosciences. Company Information Table 81. U-CyTech biosciences. Business Overview Table 82. U-CyTech biosciences. ELISpot and FluoroSpot Assay Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. U-CyTech biosciences. ELISpot and FluoroSpot Assay Product Portfolio Table 84. U-CyTech biosciences. Recent Development Table 85. North America ELISpot and FluoroSpot Assay Revenue by Type (2021-2026) & (US$ Million) Table 86. North America ELISpot and FluoroSpot Assay Revenue by Type (2027-2032) & (US$ Million) Table 87. North America ELISpot and FluoroSpot Assay Revenue by Application (2021-2026) & (US$ Million) Table 88. North America ELISpot and FluoroSpot Assay Revenue by Application (2027-2032) & (US$ Million) Table 89. North America ELISpot and FluoroSpot Assay Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America ELISpot and FluoroSpot Assay Revenue by Country (2021-2026) & (US$ Million) Table 91. North America ELISpot and FluoroSpot Assay Revenue by Country (US$ Million) & (2027-2032) Table 92. Europe ELISpot and FluoroSpot Assay Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe ELISpot and FluoroSpot Assay Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe ELISpot and FluoroSpot Assay Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe ELISpot and FluoroSpot Assay Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe ELISpot and FluoroSpot Assay Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe ELISpot and FluoroSpot Assay Revenue by Country (2021-2026) & (US$ Million) Table 98. Europe ELISpot and FluoroSpot Assay Revenue by Country (US$ Million) & (2027-2032) Table 99. China ELISpot and FluoroSpot Assay Revenue by Type (2021-2026) & (US$ Million) Table 100. China ELISpot and FluoroSpot Assay Revenue by Type (2027-2032) & (US$ Million) Table 101. China ELISpot and FluoroSpot Assay Revenue by Application (2021-2026) & (US$ Million) Table 102. China ELISpot and FluoroSpot Assay Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia ELISpot and FluoroSpot Assay Revenue by Type (2021-2026) & (US$ Million) Table 104. Asia ELISpot and FluoroSpot Assay Revenue by Type (2027-2032) & (US$ Million) Table 105. Asia ELISpot and FluoroSpot Assay Revenue by Application (2021-2026) & (US$ Million) Table 106. Asia ELISpot and FluoroSpot Assay Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia ELISpot and FluoroSpot Assay Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia ELISpot and FluoroSpot Assay Revenue by Region (US$ Million) & (2021-2026) Table 109. Asia ELISpot and FluoroSpot Assay Revenue by Region (US$ Million) & (2027-2032) Table 110. SAMEA ELISpot and FluoroSpot Assay Revenue by Type (2021-2026) & (US$ Million) Table 111. SAMEA ELISpot and FluoroSpot Assay Revenue by Type (2027-2032) & (US$ Million) Table 112. SAMEA ELISpot and FluoroSpot Assay Revenue by Application (2021-2026) & (US$ Million) Table 113. SAMEA ELISpot and FluoroSpot Assay Revenue by Application (2027-2032) & (US$ Million) Table 114. SAMEA ELISpot and FluoroSpot Assay Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. SAMEA ELISpot and FluoroSpot Assay Revenue by Country (2021-2026) & (US$ Million) Table 116. SAMEA ELISpot and FluoroSpot Assay Revenue by Country (US$ Million) & (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. ELISpot and FluoroSpot Assay Image Figure 2. Global ELISpot and FluoroSpot Assay Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global ELISpot and FluoroSpot Assay Market Size Share 2021 VS 2025 VS 2032 Figure 4. Assay Kit Image Figure 5. Analyzer Image Figure 6. Others Image Figure 7. Global ELISpot and FluoroSpot Assay Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global ELISpot and FluoroSpot Assay Market Size Share 2021 VS 2025 VS 2032 Figure 9. Diagnostic Image Figure 10. Research Image Figure 11. Global ELISpot and FluoroSpot Assay Market Size (US$ Million) & (2021-2032) Figure 12. Global ELISpot and FluoroSpot Assay Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global ELISpot and FluoroSpot Assay Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global ELISpot and FluoroSpot Assay Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global ELISpot and FluoroSpot Assay Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global ELISpot and FluoroSpot Assay Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global ELISpot and FluoroSpot Assay Revenue Market Share by Type (2021-2032) Figure 19. Global ELISpot and FluoroSpot Assay Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global ELISpot and FluoroSpot Assay Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global ELISpot and FluoroSpot Assay Revenue Market Share by Application (2021-2032) Figure 22. North America ELISpot and FluoroSpot Assay Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America ELISpot and FluoroSpot Assay Revenue Share by Type (2021-2032) Figure 24. North America ELISpot and FluoroSpot Assay Revenue Share by Application (2021-2032) Figure 25. North America ELISpot and FluoroSpot Assay Revenue Share by Country (2021-2032) Figure 26. United States ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe ELISpot and FluoroSpot Assay Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe ELISpot and FluoroSpot Assay Revenue Share by Type (2021-2032) Figure 31. Europe ELISpot and FluoroSpot Assay Revenue Share by Application (2021-2032) Figure 32. Europe ELISpot and FluoroSpot Assay Revenue Share by Country (2021-2032) Figure 33. Germany ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China ELISpot and FluoroSpot Assay Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China ELISpot and FluoroSpot Assay Revenue Share by Type (2021-2032) Figure 43. China ELISpot and FluoroSpot Assay Revenue Share by Application (2021-2032) Figure 44. Asia ELISpot and FluoroSpot Assay Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia ELISpot and FluoroSpot Assay Revenue Share by Type (2021-2032) Figure 46. Asia ELISpot and FluoroSpot Assay Revenue Share by Application (2021-2032) Figure 47. Asia ELISpot and FluoroSpot Assay Revenue Share by Region (2021-2032) Figure 48. Japan ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA ELISpot and FluoroSpot Assay Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA ELISpot and FluoroSpot Assay Revenue Share by Type (2021-2032) Figure 56. SAMEA ELISpot and FluoroSpot Assay Revenue Share by Application (2021-2032) Figure 57. SAMEA ELISpot and FluoroSpot Assay Revenue Share by Country (2021-2032) Figure 58. Brazil ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt ELISpot and FluoroSpot Assay Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Assay Kit
  • Analyzer
  • Others
Applications
  • Diagnostic
  • Research
Companies covered
  • Oxford Immunotec
  • Cellular Technology Limited
  • BD
  • AID GmbH
  • Mabtech
  • Bio-Techne
  • Lophius Biosciences
  • Abcam
  • Biotech Investissement Group
  • U-CyTech biosciences.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 ELISpot and FluoroSpot Assay Market by Type
  3. 1.2.1 Global ELISpot and FluoroSpot Assay Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Assay Kit
  5. 1.2.3 Analyzer
  6. 1.2.4 Others
  7. 1.3 ELISpot and FluoroSpot Assay Market by Application
  8. 1.3.1 Global ELISpot and FluoroSpot Assay Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Diagnostic
  10. 1.3.3 Research
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 ELISpot and FluoroSpot Assay Market Dynamics
  1. 2.1 ELISpot and FluoroSpot Assay Industry Trends
  2. 2.2 ELISpot and FluoroSpot Assay Industry Drivers
  3. 2.3 ELISpot and FluoroSpot Assay Industry Opportunities and Challenges
  4. 2.4 ELISpot and FluoroSpot Assay Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global ELISpot and FluoroSpot Assay Market Perspective (2021-2032)
  2. 3.2 Global ELISpot and FluoroSpot Assay Growth Trends by Region
  3. 3.2.1 Global ELISpot and FluoroSpot Assay Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global ELISpot and FluoroSpot Assay Market Size by Region (2021-2026)
  5. 3.2.3 Global ELISpot and FluoroSpot Assay Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global ELISpot and FluoroSpot Assay Revenue by Players
  2. 4.1.1 Global ELISpot and FluoroSpot Assay Revenue by Players (2021-2026)
  3. 4.1.2 Global ELISpot and FluoroSpot Assay Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global ELISpot and FluoroSpot Assay Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global ELISpot and FluoroSpot Assay Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global ELISpot and FluoroSpot Assay Key Players Headquarters & Area Served
  7. 4.4 Global ELISpot and FluoroSpot Assay Players, Product Type & Application
  8. 4.5 Global ELISpot and FluoroSpot Assay Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global ELISpot and FluoroSpot Assay Market CR5 and HHI
  11. 4.6.3 2025 ELISpot and FluoroSpot Assay Tier 1, Tier 2, and Tier 3
5 ELISpot and FluoroSpot Assay Market Size by Type
  1. 5.1 Global ELISpot and FluoroSpot Assay Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global ELISpot and FluoroSpot Assay Revenue by Type (2021-2032)
  3. 5.3 Global ELISpot and FluoroSpot Assay Revenue Market Share by Type (2021-2032)
6 ELISpot and FluoroSpot Assay Market Size by Application
  1. 6.1 Global ELISpot and FluoroSpot Assay Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global ELISpot and FluoroSpot Assay Revenue by Application (2021-2032)
  3. 6.3 Global ELISpot and FluoroSpot Assay Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Oxford Immunotec
  2. 7.1.1 Oxford Immunotec Company Information
  3. 7.1.2 Oxford Immunotec Business Overview
  4. 7.1.3 Oxford Immunotec ELISpot and FluoroSpot Assay Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Oxford Immunotec ELISpot and FluoroSpot Assay Product Portfolio
  6. 7.1.5 Oxford Immunotec Recent Developments
  7. 7.2 Cellular Technology Limited
  8. 7.2.1 Cellular Technology Limited Company Information
  9. 7.2.2 Cellular Technology Limited Business Overview
  10. 7.2.3 Cellular Technology Limited ELISpot and FluoroSpot Assay Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Cellular Technology Limited ELISpot and FluoroSpot Assay Product Portfolio
  12. 7.2.5 Cellular Technology Limited Recent Developments
  13. 7.3 BD
  14. 7.3.1 BD Company Information
  15. 7.3.2 BD Business Overview
  16. 7.3.3 BD ELISpot and FluoroSpot Assay Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BD ELISpot and FluoroSpot Assay Product Portfolio
  18. 7.3.5 BD Recent Developments
  19. 7.4 AID GmbH
  20. 7.4.1 AID GmbH Company Information
  21. 7.4.2 AID GmbH Business Overview
  22. 7.4.3 AID GmbH ELISpot and FluoroSpot Assay Revenue and Gross Margin (2021-2026)
  23. 7.4.4 AID GmbH ELISpot and FluoroSpot Assay Product Portfolio
  24. 7.4.5 AID GmbH Recent Developments
  25. 7.5 Mabtech
  26. 7.5.1 Mabtech Company Information
  27. 7.5.2 Mabtech Business Overview
  28. 7.5.3 Mabtech ELISpot and FluoroSpot Assay Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Mabtech ELISpot and FluoroSpot Assay Product Portfolio
  30. 7.5.5 Mabtech Recent Developments
  31. 7.6 Bio-Techne
  32. 7.6.1 Bio-Techne Company Information
  33. 7.6.2 Bio-Techne Business Overview
  34. 7.6.3 Bio-Techne ELISpot and FluoroSpot Assay Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bio-Techne ELISpot and FluoroSpot Assay Product Portfolio
  36. 7.6.5 Bio-Techne Recent Developments
  37. 7.7 Lophius Biosciences
  38. 7.7.1 Lophius Biosciences Company Information
  39. 7.7.2 Lophius Biosciences Business Overview
  40. 7.7.3 Lophius Biosciences ELISpot and FluoroSpot Assay Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Lophius Biosciences ELISpot and FluoroSpot Assay Product Portfolio
  42. 7.7.5 Lophius Biosciences Recent Developments
  43. 7.8 Abcam
  44. 7.8.1 Abcam Company Information
  45. 7.8.2 Abcam Business Overview
  46. 7.8.3 Abcam ELISpot and FluoroSpot Assay Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Abcam ELISpot and FluoroSpot Assay Product Portfolio
  48. 7.8.5 Abcam Recent Developments
  49. 7.9 Biotech Investissement Group
  50. 7.9.1 Biotech Investissement Group Company Information
  51. 7.9.2 Biotech Investissement Group Business Overview
  52. 7.9.3 Biotech Investissement Group ELISpot and FluoroSpot Assay Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Biotech Investissement Group ELISpot and FluoroSpot Assay Product Portfolio
  54. 7.9.5 Biotech Investissement Group Recent Developments
  55. 7.10 U-CyTech biosciences.
  56. 7.10.1 U-CyTech biosciences. Company Information
  57. 7.10.2 U-CyTech biosciences. Business Overview
  58. 7.10.3 U-CyTech biosciences. ELISpot and FluoroSpot Assay Revenue and Gross Margin (2021-2026)
  59. 7.10.4 U-CyTech biosciences. ELISpot and FluoroSpot Assay Product Portfolio
  60. 7.10.5 U-CyTech biosciences. Recent Developments
8 North America
  1. 8.1 North America ELISpot and FluoroSpot Assay Revenue (2021-2032)
  2. 8.2 North America ELISpot and FluoroSpot Assay Revenue by Type (2021-2032)
  3. 8.2.1 North America ELISpot and FluoroSpot Assay Revenue by Type (2021-2026)
  4. 8.2.2 North America ELISpot and FluoroSpot Assay Revenue by Type (2027-2032)
  5. 8.3 North America ELISpot and FluoroSpot Assay Revenue Share by Type (2021-2032)
  6. 8.4 North America ELISpot and FluoroSpot Assay Revenue by Application (2021-2032)
  7. 8.4.1 North America ELISpot and FluoroSpot Assay Revenue by Application (2021-2026)
  8. 8.4.2 North America ELISpot and FluoroSpot Assay Revenue by Application (2027-2032)
  9. 8.5 North America ELISpot and FluoroSpot Assay Revenue Share by Application (2021-2032)
  10. 8.6 North America ELISpot and FluoroSpot Assay Revenue by Country
  11. 8.6.1 North America ELISpot and FluoroSpot Assay Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America ELISpot and FluoroSpot Assay Revenue by Country (2021-2026)
  13. 8.6.3 North America ELISpot and FluoroSpot Assay Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe ELISpot and FluoroSpot Assay Revenue (2021-2032)
  2. 9.2 Europe ELISpot and FluoroSpot Assay Revenue by Type (2021-2032)
  3. 9.2.1 Europe ELISpot and FluoroSpot Assay Revenue by Type (2021-2026)
  4. 9.2.2 Europe ELISpot and FluoroSpot Assay Revenue by Type (2027-2032)
  5. 9.3 Europe ELISpot and FluoroSpot Assay Revenue Share by Type (2021-2032)
  6. 9.4 Europe ELISpot and FluoroSpot Assay Revenue by Application (2021-2032)
  7. 9.4.1 Europe ELISpot and FluoroSpot Assay Revenue by Application (2021-2026)
  8. 9.4.2 Europe ELISpot and FluoroSpot Assay Revenue by Application (2027-2032)
  9. 9.5 Europe ELISpot and FluoroSpot Assay Revenue Share by Application (2021-2032)
  10. 9.6 Europe ELISpot and FluoroSpot Assay Revenue by Country
  11. 9.6.1 Europe ELISpot and FluoroSpot Assay Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe ELISpot and FluoroSpot Assay Revenue by Country (2021-2026)
  13. 9.6.3 Europe ELISpot and FluoroSpot Assay Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China ELISpot and FluoroSpot Assay Revenue (2021-2032)
  2. 10.2 China ELISpot and FluoroSpot Assay Revenue by Type (2021-2032)
  3. 10.2.1 China ELISpot and FluoroSpot Assay Revenue by Type (2021-2026)
  4. 10.2.2 China ELISpot and FluoroSpot Assay Revenue by Type (2027-2032)
  5. 10.3 China ELISpot and FluoroSpot Assay Revenue Share by Type (2021-2032)
  6. 10.4 China ELISpot and FluoroSpot Assay Revenue by Application (2021-2032)
  7. 10.4.1 China ELISpot and FluoroSpot Assay Revenue by Application (2021-2026)
  8. 10.4.2 China ELISpot and FluoroSpot Assay Revenue by Application (2027-2032)
  9. 10.5 China ELISpot and FluoroSpot Assay Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia ELISpot and FluoroSpot Assay Revenue (2021-2032)
  2. 11.2 Asia ELISpot and FluoroSpot Assay Revenue by Type (2021-2032)
  3. 11.2.1 Asia ELISpot and FluoroSpot Assay Revenue by Type (2021-2026)
  4. 11.2.2 Asia ELISpot and FluoroSpot Assay Revenue by Type (2027-2032)
  5. 11.3 Asia ELISpot and FluoroSpot Assay Revenue Share by Type (2021-2032)
  6. 11.4 Asia ELISpot and FluoroSpot Assay Revenue by Application (2021-2032)
  7. 11.4.1 Asia ELISpot and FluoroSpot Assay Revenue by Application (2021-2026)
  8. 11.4.2 Asia ELISpot and FluoroSpot Assay Revenue by Application (2027-2032)
  9. 11.5 Asia ELISpot and FluoroSpot Assay Revenue Share by Application (2021-2032)
  10. 11.6 Asia ELISpot and FluoroSpot Assay Revenue by Country
  11. 11.6.1 Asia ELISpot and FluoroSpot Assay Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia ELISpot and FluoroSpot Assay Revenue by Country (2021-2026)
  13. 11.6.3 Asia ELISpot and FluoroSpot Assay Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA ELISpot and FluoroSpot Assay Revenue (2021-2032)
  2. 12.2 SAMEA ELISpot and FluoroSpot Assay Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA ELISpot and FluoroSpot Assay Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA ELISpot and FluoroSpot Assay Revenue by Type (2027-2032)
  5. 12.3 SAMEA ELISpot and FluoroSpot Assay Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA ELISpot and FluoroSpot Assay Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA ELISpot and FluoroSpot Assay Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA ELISpot and FluoroSpot Assay Revenue by Application (2027-2032)
  9. 12.5 SAMEA ELISpot and FluoroSpot Assay Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA ELISpot and FluoroSpot Assay Revenue by Country
  11. 12.6.1 SAMEA ELISpot and FluoroSpot Assay Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA ELISpot and FluoroSpot Assay Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA ELISpot and FluoroSpot Assay Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst